| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Former 10% Owner | 10% Owner | 10% Owner, See Remarks +3 more
5 companies
Palihapitiya Chamath is a Former CEO And Director at SOFI, with reported holdings spanning 5 companies. Recent filings cover 2 purchases and 48 sales. Those positions are worth an estimated $241.0M at current prices.
Our model assigns Palihapitiya Chamath a middling insider score of 62/100, based on 35 past trades. Over a 12-month horizon, 54.3% of those trades were profitable, with an average 12-month return of +4.6%.
Palihapitiya Chamath's largest disclosed position is in SOFI as Former CEO And Director, worth about $131.0M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 10, 2023 | PROK Prokidney Corp. | 10% Owner | Sell | 277,621 | $4.42 | $1,227,465.52 | -2.9% | -67.2% | -62.1% | |
| Sep 19, 2023 | PROK Prokidney Corp. | 10% Owner | Sell | 1,700,000 | $5.47 | $9,299,000.00 | -45.1% | -63.9% | -50.7% | |
| Nov 22, 2021 | CLOV Clover Health Investments, Corp. /de | 10% Owner, See Remarks | Buy | 1,739,130 | $5.75 | $9,999,997.50 | New | -62.4% | -77.0% | |
| Mar 3, 2021 | SPCE Virgin Galactic Holdings, Inc | Director, 10% Owner | Sell | 6,200,000 | $34.32 | $212,771,951.36 | -100% | - | - | |
| Dec 15, 2020 | SPCE Virgin Galactic Holdings, Inc | Director, 10% Owner | Sell | 3,800,000 | $25.74 | $97,826,680.32 | -38.0% | - | - | |
| Oct 25, 2019 | SPCE Virgin Galactic Holdings, Inc | Director, 10% Owner | Buy | 10,000,000 | $10.00 | $100,000,000.00 | New | - | - |